Development of nanomedicines will target specific cells without compromising immunity

University at Buffalo researcher examines role of little-studied IgM in Sjögren’s syndrome

“Control and enforcement agencies such as the FDA stringently supervise the pharmaceutical industry, but the food additive market remains unsupervised enough.”